RenovoRx, Inc. (NASDAQ:RNXT) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert J. Spiegel Other companies: Ernexa Therapeutics Inc. (Director · Since at least Sep 14, 2026); Geron Corporation (Director · Since at least Sep 29, 2017); Athenex Inc (Director · Aug 4, 2020 – Apr 21, 2023 · Past); Ayala Pharmaceuticals Inc (Director · May 7, 2020 – Jan 19, 2023 · Past); Bio Green Med Solution, Inc. (Director · Sep 6, 2018 – Jun 30, 2023 · Past); PDS Biotechnology Corporation (Director · Jun 19, 2018 – Mar 15, 2019 · Past); Sucampo Pharmaceuticals Inc (Director · Feb 13, 2018 – Feb 13, 2018 · Past) | Director · Since at least Apr 25, 2023 |
| James M. Ahlers Other companies: Cue Biopharma, Inc. (Chief Financial Officer · Since at least Jul 30, 2026); Intensity Therapeutics, Inc. (Executive Vice President · Since at least Jun 29, 2023) | Chief Financial Officer · Jul 15, 2022 – Jul 15, 2022 · Past |
| Laurence J. Marton Other companies: Matternet Inc (Director · Since at least May 22, 2026) | Director · Since at least Apr 8, 2025 |
| Angela Macfarlane | Director · Since at least Nov 20, 2026 |
| Angela Nelms | Chief Operating Officer · Sep 19, 2022 – Jan 19, 2024 · Past |
| Leesa Gentry | Chief Clinical Officer · Since at least Mar 1, 2024 |
| Mark Voll | Chief Financial Officer · Since at least Feb 5, 2026 |
| Phil Stocton | Vice President of Sales and Market Development · Aug 14, 2025 – Nov 20, 2026 · Past |
| Ramtin Agah | Chairman, Chief Medical Officer, and Founder · Since at least Feb 27, 2026 |
| Richard Stark | Director · Since at least Nov 19, 2026 |
| Ronald B. Kocak | Vice President of Finance and Controller · Since at least Feb 5, 2026 |
| Shaun R. Bagai | Director and Chief Executive Officer · Since at least Aug 25, 2021 |
| Tom Kelly | VP of Operations and Quality · Since at least Nov 20, 2026 |
| Una S. Ryan | Director · Since at least Mar 3, 2022 |